BIND Therapeutics Files Registration Statement for Proposed Initial Public Offering

 
By 12 August 2013
SHARE :

BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it has filed a registration statement on Form S-1 with the U.S.
(read the story…)